Drug Shortage Report for LITHMAX

Last updated on 2025-12-08 History
Report ID 261865
Drug Identification Number 02266695
Brand name LITHMAX
Common or Proper name LITHMAX
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) LITHIUM CARBONATE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N05AN
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-07-02
Actual start date
Estimated end date 2025-12-03
Actual end date 2025-12-02
Shortage status Resolved
Updated date 2025-12-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-12-08 French Compare
v15 2025-12-08 English Compare
v14 2025-11-07 French Compare
v13 2025-11-07 English Compare
v12 2025-10-08 French Compare
v11 2025-10-08 English Compare
v10 2025-09-17 French Compare
v9 2025-09-17 English Compare
v8 2025-08-27 French Compare
v7 2025-08-27 English Compare
v6 2025-08-13 French Compare
v5 2025-08-13 English Compare
v4 2025-08-08 French Compare
v3 2025-08-08 English Compare
v2 2025-07-04 French Compare
v1 2025-07-04 English Compare

Showing 1 to 16 of 16